Cargando…
Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy
The aim of this study was to characterize the role of nucleotide-binding oligomerization domain- (NOD-) like receptor (NLR) protein 3 (NLRP3) inflammasome activation in the onset of diabetic retinopathy (DR) using retina and vitreous from donors without diabetes mellitus (CTL), with diabetes mellitu...
Autores principales: | Kuo, Charisse Y-J., Maran, Jack J., Jamieson, Emma G., Rupenthal, Ilva D., Murphy, Rinki, Mugisho, Odunayo O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697159/ https://www.ncbi.nlm.nih.gov/pubmed/36430950 http://dx.doi.org/10.3390/ijms232214471 |
Ejemplares similares
-
Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum – a systematic review
por: Kuo, Charisse Y. J., et al.
Publicado: (2022) -
NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease
por: Zhuang, Dian, et al.
Publicado: (2023) -
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy
por: Lyon, Heather, et al.
Publicado: (2020) -
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy
por: Mugisho, Odunayo O., et al.
Publicado: (2023) -
Immunohistochemical Characterization of Connexin43 Expression in a Mouse Model of Diabetic Retinopathy and in Human Donor Retinas
por: Mugisho, Odunayo O., et al.
Publicado: (2017)